STAT+: How the FDA’s pandemic flexibilities boosted mental health apps — and what happens now
The FDA's pandemic flexibilities gave a major boost to mental health apps. What happens now?
In April 2020, the Food and Drug Administration announced a pandemic enforcement policy allowing mental health app developers to release certain treatment products without seeking authorization from the agency. With the end of the official public health emergency, companies that did so will now need to submit the products for FDA clearance and have them pass an early stage of review by early November — or remove the products from the market.
The enforcement policy afforded developers the ability to experiment with their products in the real world and advance their clinical, regulatory, and commercial strategies in clever ways. There’s no official count of how many companies released mental health apps under the policy, but STAT spoke to seven last year. Regulators have been discussing plans for how to eventually rein in the loosened rules since late 2021.
What's Your Reaction?
